IL17A and COVID-19: Also, pathways such as HIF-1 response [67], PI3K-Akt signaling [68], and IL-17 signaling [69] were also found deregulated, which could assist the COVID-19 patients suffering from hypoxia, lung injury, and inflammation of the respiratory tract.